title: [99m-Technetium-mercaptoacetyltriglycine (MAG3) for the demonstration of the kidney changes following extracorporeal shockwave lithotripsy. A prospective study of 117 patients].
abstract: Extracorporeal shock wave lithotripsy (ESWL) has become the treatment of choice for urinary calculi. 117 patients were studied prospectively with 99mTc mercaptoacetyltriglycine (MAG3) before and after ESWL. 79 (66%) of the 119 kidneys treated had abnormal findings. Of these 63/119 (53%) had abnormal scans. 41 (65%) had focal lesions with a delayed intrarenal transport. The remaining 22 had a diffuse delay of intrarenal transport. A loss of relative renal function of 3% and more compared to the pretreatment values was observed in 50/119 (42%) patients. 99mTc MAG3 should be done routinely together with radiologic tests (CT or MRI) before and after ESWL to select the patients at risk for post ESWL hypertension.
authors.affiliation: Klinik mit Poliklinik für Radiologie, Johannes-Gutenberg-Universität, Mainz.
authors.forename: T
authors.initials: T
authors.lastname: Schaub
authors.forename: U
authors.initials: U
authors.lastname: Witsch
authors.forename: H
authors.initials: H
authors.lastname: el-Damanhoury
authors.forename: B
authors.initials: B
authors.lastname: Nägele-Wöhrle
authors.forename: K
authors.initials: K
authors.lastname: Hahn
mesh_terms: D005260:Female; D015902:Gamma Cameras; D006801:Humans; D007668:Kidney / Q000000981:diagnostic imaging* / Q000503:physiopathology; D007669:Kidney Calculi / Q000150:complications / Q000000981:diagnostic imaging / Q000628:therapy; D007674:Kidney Diseases / Q000000981:diagnostic imaging* / Q000453:epidemiology / Q000209:etiology; D008096:Lithotripsy / Q000009:adverse effects / Q000706:statistics & numerical data; D008297:Male; D011446:Prospective Studies; D011877:Radionuclide Imaging; D017263:Technetium Tc 99m Mertiatide; D013997:Time Factors
chemical_list: D017263:Technetium Tc 99m Mertiatide